Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Atopic Dermatitis Treatment Market: By Drug Class: Corticosteroids, Calcineurin Inhibitors, Immunosuppressant, Others; By Mode of Administration; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Atopic Dermatitis Treatment Market Outlook

The market for atopic dermatitis treatment reached about USD 9.67 billion in 2021. The industry is further expected to grow at a CAGR of about 8.7% in the forecast period of 2022-2027. It will reach an approximate value of USD 15.86 billion by the end of 2027, driven by the rising awareness about the importance of treatment among the people.

 

North America is Leading the Atopic Dermatitis Treatment Market

North America is expected to hold a significant share of the global atopic dermatitis market. The influencing factors include the growing number of people suffering from skin disorders, rapid climate changes, the thriving population and increasing disposable income. The increasing awareness about the importance of treatment is making people more inclined to follow the procedures and get the cure, which increases the significance of the atopic dermatitis treatment market.

The United States and Canada have well-established and advanced healthcare infrastructures. With the early adoption of novel prescriptions and improved and favourable reimbursement regulations, it is made possible for patients to go for the services provided without facing any burdens. Furthermore, pharmaceutical companies are growing their business relations with research organisations to target the developing region by increasing their investments in R&D to make advancements and focus on launching new products. With the technological advances and the introduction of new procedures in the medical field, the market is likely to grow further in the coming years.

 

Market Segmentation: Atopic Dermatitis Treatment Market

Atopic dermatitis, also known as eczema, is a skin condition where the patient's skin gets red, itchy, dry, and bumpy. It usually develops in early childhood but can occur at any age, and the likelihood of getting dermatitis increases if the person's family has a genetic history of atopic dermatitis.

The market for atopic dermatitis treatment, by drug class, can be broadly divided into:

  • Corticosteroids
  • Calcineurin Inhibitors
  • Immunosuppressant
  • Biologic Therapy
  • PDE-4 Inhibitor
  • Antibiotics
  • Antihistamines
  • Emollients

The modes of administration in the market are as follows:

  • Topical
  • Oral
  • Injectable

By distribution channels, the market for atopic dermatitis treatment can be divided into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
  • Dermatology Clinics
  • Others

Regional atopic disease treatment markets can be divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

 

The Rising Initiatives to Spread Awareness About Treatments are Driving the Market

Skin problems like allergies and chronic disorders are increasing, and with the rapid climate changes, these disorders will not slow down anytime soon. Growing investments in healthcare can accelerate the market's growth as the dermatology sector has been rising rapidly. Medical Organizations are collaborating with the governments to develop new procedures and policies, equipping the institutes with state-of-the-art technology to support the increasing number of patients and let them avail the treatments easily, which shows promising growth for the market.

The key players are focusing on mergers and collaborations with leading players of foreign regions to build their presence in foreign markets and make product advancements with the collaborative effort. They are creating novel prescriptions and cost-effective treatments for the developing countries and people who are unable to afford to top of the line options. The thriving population of countries like China and India having a massive population shows excellent scope for growth of the atopic dermatitis treatment market.

 

Key Players in the Global Market for Atopic Dermatitis Treatment

The report gives a detailed analysis of the following key players in the global atopic dermatitis treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, investments, expansions of capacity, and plant turnarounds:

  • Pfizer Inc.
  • Astellas Pharma Inc.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Sanofi SA
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Mode of Administration
  • Distribution Channel
  • Region
Breakup by Drug Class
  • Corticosteroids
  • Calcineurin Inhibitors
  • Immunosuppressant
  • Biologic Therapy
  • PDE-4 Inhibitor
  • Antibiotics
  • Antihistamines
  • Emollients
Breakup by Mode of Administration
  • Topical
  • Oral
  • Injectable
Breakup by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores
  • Dermatology Clinics
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Pfizer Inc.
  • Astellas Pharma Inc.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Sanofi SA
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface 
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions   
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Region
7    Opportunities and Challenges in the Market
8    Global Atopic Dermatitis Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Atopic Dermatitis Treatment Historical Market (2017-2021) 
    8.3    Global Atopic Dermatitis Treatment Market Forecast (2022-2027)
    8.4    Global Atopic Dermatitis Treatment Market by Drug Class
        8.4.1    Corticosteroids
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Calcineurin Inhibitors
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Immunosuppressant
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Biologic Therapy
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
        8.4.5    PDE-4 Inhibitor
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2017-2021)
            8.4.5.3    Forecast Trend (2022-2027)
        8.4.6    Antibiotics
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2017-2021)
            8.4.6.3    Forecast Trend (2022-2027)
        8.4.7    Antihistamines
            8.4.7.1    Market Share
            8.4.7.2    Historical Trend (2017-2021)
            8.4.7.3    Forecast Trend (2022-2027)
        8.4.8    Emollients
            8.4.8.1    Market Share
            8.4.8.2    Historical Trend (2017-2021)
            8.4.8.3    Forecast Trend (2022-2027)
    8.5    Global Atopic Dermatitis Treatment Market by Mode of Administration
        8.5.1    Topical
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Oral
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Injectable
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
    8.6    Global Atopic Dermatitis Treatment Market by Distribution Channel
        8.6.1    Hospital Pharmacies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Retail Pharmacies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Online Pharmacies
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Drug Stores
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Dermatology Clinics
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021)
            8.6.5.3    Forecast Trend (2022-2027)
        8.6.6    Others
    8.7    Global Atopic Dermatitis Treatment Market by Region
        8.7.1    North America
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021) 
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Europe
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021) 
            8.7.2.3    Forecast Trend (2022-2027)
        8.7.3    Asia Pacific
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2017-2021) 
            8.7.3.3    Forecast Trend (2022-2027)
        8.7.4    Latin America
            8.7.4.1    Market Share
            8.7.4.2    Historical Trend (2017-2021) 
            8.7.4.3    Forecast Trend (2022-2027)
        8.7.5    Middle East and Africa
            8.7.5.1    Market Share
            8.7.5.2    Historical Trend (2017-2021) 
            8.7.5.3    Forecast Trend (2022-2027)
9    North America Atopic Dermatitis Treatment Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2017-2021) 
        9.1.3    Forecast Trend (2022-2027)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2017-2021) 
        9.2.3    Forecast Trend (2022-2027)
10    Europe Atopic Dermatitis Treatment Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2017-2021) 
        10.1.3    Forecast Trend (2022-2027)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2017-2021) 
        10.2.3    Forecast Trend (2022-2027)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2017-2021) 
        10.3.3    Forecast Trend (2022-2027)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2017-2021) 
        10.4.3    Forecast Trend (2022-2027)
    10.5    Others
11    Asia Pacific  Atopic Dermatitis Treatment Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2017-2021) 
        11.1.3    Forecast Trend (2022-2027)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2017-2021) 
        11.2.3    Forecast Trend (2022-2027)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2017-2021) 
        11.3.3    Forecast Trend (2022-2027)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2017-2021) 
        11.4.3    Forecast Trend (2022-2027)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2017-2021) 
        11.5.3    Forecast Trend (2022-2027)
    11.6    Others
12    Latin America Atopic Dermatitis Treatment Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2017-2021) 
        12.1.3    Forecast Trend (2022-2027)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2017-2021) 
        12.2.3    Forecast Trend (2022-2027)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2017-2021) 
        12.3.3    Forecast Trend (2022-2027)
    12.4    Others
13    Middle East and Africa Atopic Dermatitis Treatment Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2017-2021) 
        13.1.3    Forecast Trend (2022-2027)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2017-2021) 
        13.2.3    Forecast Trend (2022-2027)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2017-2021) 
        13.3.3    Forecast Trend (2022-2027)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2017-2021) 
        13.4.3    Forecast Trend (2022-2027)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Pfizer Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Astellas Pharma Inc.
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    AbbVie Inc.
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Bristol-Myers Squibb Company
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Sanofi SA
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends  and Developments in the Market

 

List of Key Figures and Tables

1.    Global Atopic Dermatitis Treatment Market: Key Industry Highlights, 2017 and 2027
2.    Global Atopic Dermatitis Treatment Historical Market: Breakup by Drug Class (USD Billion), 2017-2021
3.    Global Atopic Dermatitis Treatment Market Forecast: Breakup by Drug Class (USD Billion), 2022-2027
4.    Global Atopic Dermatitis Treatment Historical Market: Breakup by Mode of Administration (USD Billion), 2017-2021
5.    Global Atopic Dermatitis Treatment Market Forecast: Breakup by Mode of Administration (USD Billion), 2022-2027
6.    Global Atopic Dermatitis Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
7.    Global Atopic Dermatitis Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
8.    Global Atopic Dermatitis Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Atopic Dermatitis Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Atopic Dermatitis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Atopic Dermatitis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Atopic Dermatitis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Atopic Dermatitis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Atopic Dermatitis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Atopic Dermatitis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Atopic Dermatitis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Atopic Dermatitis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Atopic Dermatitis Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Atopic Dermatitis Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global Atopic Dermatitis Treatment Market Structure.

Key Questions Answered in the Report

In 2021, the global district heating market attained a value of nearly USD 9.67 billion.

The market is projected to grow at a CAGR of 8.7% between 2022 and 2027.

The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach USD 15.86 billion by 2027.

The primary industry drivers include the rising dermatology sector, increasing initiatives to spread awareness about the treatment, and the rising competition among the key players.

The collaboration with the government to improvise the policies and procedures of the treatment is a key driver propelling market growth.

The major regions in the industry are North America, Latin America, the Middle East, Africa, Europe, and the Asia Pacific, with North America being the most prominent market region.

In the atopic dermatitis treatment, the drug class can be divided into Corticosteroids, Calcineurin inhibitors, immunosuppressants, Biologic Therapy, PDE-4 inhibitors, antibiotics, antihistamines, and emollients.

The modes of administration can be segmented into topical, oral, and injectable.

The distribution channels of the market include hospital pharmacies, retail pharmacies, online pharmacies, drug stores, and dermatology clinics, among others.

The major players in the industry are Pfizer Inc., Astellas Pharma Inc., AbbVie Inc., Bristol-Myers Squibb Company, and Sanofi SA, among others.

Analyst Review

The atopic dermatitis treatment market attained a value of USD 9.67 billion in 2021, driven by the rising inclination towards renewable energy sources and carbon emission control. Aided by the growing energy needs, the market is expected to grow at a CAGR of 8.7% in the forecast period of 2022-2027. The market is projected to reach USD 15.86 billion by 2027.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug class, the global atopic dermatitis treatment market can be segmented into Corticosteroids, Calcineurin inhibitors, immunosuppressants, Biologic Therapy, PDE-4 inhibitors, antibiotics, antihistamines, and emollients. Modes of administration can be divided into topical, oral, and injectable. The distribution channel can be divided into hospital pharmacies, retail pharmacies, online pharmacies, drug stores, and dermatology clinics, among others. The market regions can be divided into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa, with North America being the most established region. The key industry players include Pfizer Inc., Astellas Pharma Inc., AbbVie Inc., Bristol-Myers Squibb Company, and Sanofi SA, among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER